Failure of rifampin to eradicate group B streptococcal colonization in infants

Pediatric Infectious Disease Journal

Volumn 20, Issue 4, 2001, Pages 371-376

  Fernandez, Marisol ^a   Rench, Marcia A ^a   Albanyan, Esam A ^a   Edwards, Morven S ^a   Baker, Carol J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Colonization; Group B Streptococcus; Infant; Rifampin

Indexed keywords

RIFAMPICIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; MUCOSA; PRIORITY JOURNAL; RECURRENT DISEASE; STREPTOCOCCUS AGALACTIAE; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; HUMANS; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; MUCOUS MEMBRANE; RIFAMPIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TREATMENT FAILURE;

EID: 0035071511     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200104000-00002     Document Type: Article

References (31)

1. Infant with two relapses of group B streptococcal sepsis documented by DNA restriction enzyme analysis
2. Recurrent group B streptococcal disease in infants: Who should receive rifampin?
3. Recurrent group B streptococcal infections in infants: Clinical and microbiologic aspects
4. Multiple group B streptococcal infections in a premature infant: Eradication of nasal colonization with rifampin
5. Serologic differentiation of specific types of bovine hemolytic streptococci
6. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: Criteria for bacterial strain typing
7. A 5-year review of recurrent group B streptococcal disease: Lessons from twin infants
8. Neonatal sepsis caused simultaneously by two serotypes of group B Streptococcus
9. Efficacy of rifampin in treatment of meningococcal carriers
10. Effect of rifampin chemoprophylaxis on carriage eradication and new acquisition of Haemophilus influenzae type b in contacts
11. Failure of penicillin to eradicate the carrier state of group B streptococcus in infants
12. Haemophilus influenzae infections
13. 90 and eradication of nasopharyngeal carriage of bacteria
14. Pharmacokinetics of rifampin in infants and children: Relevance to prophylaxis against Haemophilus influenzae type b disease
15. Rifampin and penicillin for the elimination of group B streptococci in nasally colonized infant rats
16. Effect of rifampin on ampicillin killing of group B streptococci
17. In vitro activity of penicillin and rifampin against group B streptococci
18. Rifampin: Spectrum of antibacterial activity
19. Efficacy of rifampin in eliminating pharyngeal carriage of Haemophilus influenzae type b
20. Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type b
21. Isolation of group B streptococci from the proximal small intestine of adults
22. Penicillin V and rifampin for the treatment of group A streptococcal pharyngitis: A randomized trial of 10 days penicillin vs 10 days penicillin with rifampin during the final 4 days of therapy
23. Penicillin plus rifampin eradicates pharyngeal carriage of group A streptococci
24. Treatment failures and carriers: Perception or problem?
25. Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis
26. Recurrent group B streptococcal disease in an infant associated with the ingestion of infected mother's milk
27. Group B streptococcal breast abscess in a mother and mastitis in her infant
28. Analysis of DNA restriction fragment length polymorphism extends the evidence for breast milk transmission in Streptococcus agalactiae late-onset neonatal infection
29. Clindamycin treatment of chronic pharyngeal carriage of group A streptococci
30. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis